Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The broad innate and adaptive immune system is the collective network of cells, tissues, and organs that defend the body against pathogens and maintain tissue homeostasis (StatPearls, 2023). The innate immune system provides immediate, non-specific protection through physical barriers, antimicrobial peptides, and cells like macrophages and neutrophils (NIH, 2024). The adaptive immune system, involving B and T lymphocytes, offers highly specific recognition of antigens and the development of long-term immunological memory (Janeway's Immunobiology, 2017). Dysfunction in these systems can lead to a wide range of diseases, including autoimmune disorders, chronic inflammation, and immunodeficiencies (PubMed, 2022). Because this term encompasses thousands of distinct molecular entities and pathways, it is not a valid therapeutic target for drug development; instead, specific components such as cytokines or receptors are targeted (Nature Reviews Drug Discovery, 2021).
Not applicable as this refers to a physiological system rather than a specific molecular target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Broad innate and adaptive immune system.